08:00 , Nov 20, 2014 |  BC Innovations  |  Distillery Therapeutics

Indication: Neurology

Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Amyotrophic lateral sclerosis (ALS) Adducin 1 (ADD1); ATPase Na+/K+ transporting a2 polypeptide (ATP1A2) In vitro and mouse...